ONWARD Medical

ONWARD Medical FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of ONWARD Medical (ONWD.BR) as of Oct 23, 2026 is 94.52 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 89.33 % — a change of 5.81% (higher).

FCF Conversion

94.52 %

YoY

5.81%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of ONWARD Medical is 2025 94.52 % . FCF Conversion Rate (FCF/EBITDA) of ONWARD Medical was 2024 89.33 % . It decreases by 5.81% higher compared to the previous year.

The ONWARD Medical FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
73.23 EUR
Jan 1, 2019
73.94 EUR
Jan 1, 2020
65.32 EUR
Jan 1, 2021
64.69 EUR
Jan 1, 2022
82.70 EUR
Jan 1, 2023
90.36 EUR
Jan 1, 2024
89.33 EUR
Jan 1, 2025
94.52 EUR
The ONWARD Medical FCF Conversion history
YEARFCF ConversionYoY
94.52 %+5.81%
89.33 %-1.14%
90.36 %+9.26%
82.70 %+27.84%
64.69 %-0.97%
65.32 %-11.65%
73.94 %+0.96%
73.23 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

ONWARD Medical Stock analysis

What does ONWARD Medical do? Onward Medical NV, headquartered in Eindhoven, Netherlands, operates in the Health Care sector with a focus on developing innovative therapies for spinal cord injury recovery. The company, which has 96 employees, went public on 21 October 2021. It develops two technology platforms, ARC EX and ARC IM, aimed at enabling functional recovery for patients with spinal cord injuries. ONWARD Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ONWARD Medical stock

FCF Conversion Rate (FCF/EBITDA) of ONWARD Medical is 94.52 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of ONWARD Medical changed from 89.33 % to 94.52 %, representing a 5.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) ONWARD Medical since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s ONWARD Medical with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — ONWARD Medical

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — ONWARD Medical